| Product Name | MF | CAS | Details |
|---|
| 2-[3-(Ethoxycarbonyl)piperidin-1-yl]acetic acid | C10H17NO4 | 1283109-01-2 | Details |
| 2-Cyclobutyl-2-methylpropanenitrile | C8H13N | 1849197-83-6 | Details |
| H-SGYETFR-OH | Details |
| 4,6-Difluoroisatin | C8H3F2NO2 | 126674-93-9 | Details |
| N-[(1R)-1-(1-Naphthalenyl)ethyl]carbamic acid 3-[3-(trifluoromethyl)phenyl]propyl] ester | C23H22F3NO2 | 915979-44-1 | Details |
| 1-Ethyl-1H-1,2,3-triazole-4-sulfonyl chloride | C4H6ClN3O2S | 1393568-12-1 | Details |
| tert-Butyl octahydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate | C12H22N2O2 | 1251010-63-5 | Details |
| LST-3TM12 antibody | Details |
| 2-amino-1-(1-aza-4-phenylbuta-1,3-dienyl)ethene-1,2-dicarbonitrile | C13H10N4 | 55083-91-5 | Details |
| CD19 antibody (Allophycocyanin-CY7) | Details |
| 3-Chloro-3-phenyl-1-propene | C9H9Cl | 4392-26-1 | Details |
| [(2,4-Difluorophenyl)methyl][2-(dimethylamino)ethyl]amine | C11H16F2N2 | 926258-92-6 | Details |
| NFKB1 antibody (FITC) | Details |
| 3-(Cyclopentylsulfamoyl)benzoic acid | C12H15NO4S | 893761-09-6 | Details |
| tert-Butyl 1-(2,2,2-trifluoroethyl)pyrrolidine-3-carboxylate | C11H18F3NO2 | 1803608-99-2 | Details |
| 2-(4-Methanesulfinylphenyl)acetic acid | C9H10O3S | 118362-28-0 | Details |
| PDCD1 antibody | Details |
| 2-Benzoylpyrimidine | C11H8N2O | 112170-34-0 | Details |
| Dimethyl-D-tartrate | C6H10O6 | 13171-64-7 | Details |
| (1R)-1-(5,6,7,8-Tetrahydronaphthalen-2-yl)ethan-1-amine hydrochloride | C12H18ClN | 1461689-29-1 | Details |
| HCMV pp65 363-373 (HLA-A*01:01) | Details |
| HIRIP3 Blocking Peptide | Details |
| 4-Chloro-8-propoxyquinoline | C12H12ClNO | 1156602-06-0 | Details |
| 2-Sulfamoylbenzene-1-sulfonyl chloride | C6H6ClNO4S2 | 100704-37-8 | Details |
| (2,3-Dimethylphenyl)hydrazine hydrochloride | C8H13ClN2 | 56737-75-8 | Details |
| Diaminophosphoryloxybenzene | C6H9N2O2P | 7450-69-3 | Details |
| 5-Amino-1H-imidazole-4-carboxamide | C4H6N4O | 360-97-4 | Details |
| Selaginellin F | C34H24O6 | 1340493-24-4 | Details |
| 2-Pyridin-3-yl-1H-benzoimidazol-5-ylamine | C12H10N4 | 1571-99-9 | Details |
| 3-Fluoro-4-(2-hydroxyphenoxy)benzonitrile | C13H8FNO2 | 1183090-50-7 | Details |
| 4,4-difluoroadamantane-1-carboxylic acid | C11H14F2O2 | 438017-43-7 | Details |
| 1-(2-Fluoroethyl)-3-methyl-1H-pyrazol-4-amine | C6H10FN3 | 1427010-60-3 | Details |
| N-(3-Hydroxyphenyl)-2-furamide | C11H9NO3 | 55679-22-6 | Details |
| H-IVSPFIPLL-OH | Details |
| rac-Benzyl (3R,4R)-3-hydroxy-4-(methylamino)pyrrolidine-1-carboxylate | C13H18N2O3 | 1224172-60-4 | Details |
| 2-Cyclobutoxyacetic acid | C6H10O3 | 189956-41-0 | Details |
| WZ811 | C18H18N4 | 55778-02-4 | Details |
| 2-Vinyl-1H-benzimidazole | C9H8N2 | 14984-26-0 | Details |
| WDR89 antibody | Details |
| (2-Amino-6-methoxyphenyl)methanol | C8H11NO2 | 177531-95-2 | Details |
| Cholesteryl-teg azide | C36H62N4O5 | 1391826-58-6 | Details |
| 1-(Morpholine-4-carbonyl)piperidine-4-carboxylic acid | C11H18N2O4 | 1018574-31-6 | Details |
| 2-[3-(Aminomethyl)phenoxy]-N-cyclopropylacetamide hydrochloride | C12H16N2O2·HCl | 1221723-43-8 | Details |
| 2-Chloro-6,7-dimethylquinoline-3-carboxaldehyde | C12H10ClNO | 94856-39-0 | Details |
| 1-(2,4-Dimethylphenyl)-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylic acid | C12H12N2O3 | 1204296-99-0 | Details |
| 3-Methyl-3,8-diaza-bicyclo[3.2.1]octane | C7H14N2 | 51102-41-1 | Details |
| {4-[3,3-Bis-(4-bromo-phenyl)-allylsulfanyl]-2-chloro-phenoxy}-acetic acid | C23H17Br2ClO3S | 685139-10-0 | Details |
| 4-Hydroxy-1-(2,4,5-trichlorophenyl)-1H-pyrazole-3-carboxylic acid | C10H5Cl3N2O3 | 1152972-73-0 | Details |
| VPS26A antibody | Details |
| Gestrinone antibody | Details |
| (3,3-Difluoropropyl)(methyl)amine hydrochloride | C4H10ClF2N | 2219378-66-0 | Details |
| RSV IgM Positive Human Plasma | Details |
| 4-Formyl-Benzamido-dPEG?12-TFP Ester | Details |
| 3-Bromo-2-fluoro-6-methoxybenzoic acid | C8H6BrFO3 | 1449008-25-6 | Details |
| [6-(Difluoromethoxy)pyridin-2-yl]methanol | C7H7F2NO2 | 1375098-11-5 | Details |
| 2-Chloro-N-[(2-chloro-6-fluorophenyl)methyl]-N-methylpropanamide | C11H12Cl2FNO | 1154151-13-9 | Details |
| 2-Methoxy-5-(pyridin-3-yl)aniline dihydrochloride | C12H13ClN2O | 2219374-27-1 | Details |
| 2-[(Quinolin-2-yl)amino]ethan-1-ol | C11H12N2O | 332409-62-8 | Details |
| 3-(Benzyloxy)butan-2-one | C11H14O2 | 113133-46-3 | Details |
| Methyl 4-aminothiane-4-carboxylate hydrochloride | C7H13NO2S.ClH | 161315-14-6 | Details |
| 1-Phenylpentane-1,3-dione | C11H12O2 | 5331-64-6 | Details |
| 1-(3,5-Dichlorophenyl)-2-methylpropan-1-ol | C10H12Cl2O | 1341140-47-3 | Details |
| 2’-Deoxy-N2-DMF-2’-fluoroguanosine | Details |
| ((3,4,5-trimethoxyphenyl)methylene)methane-1,1-dicarbonitrile | C13H12N2O3 | 5688-82-4 | Details |
| 1-[4-(Chloromethyl)piperidin-1-yl]ethan-1-one | C8H14ClNO | 865074-93-7 | Details |
| 5-Bromo-2,3-dihydro-1H-indole-6-sulfonamide | C8H9BrN2O2S | 2066546-05-0 | Details |
| SF3B1 antibody | Details |
| Z-N-Me-D-Ser(tBu)-OH·DCHA | C16H23NO5 | 1589095-95-3 | Details |
| OXER1 antibody | Details |
| TSG protein | Details |
| 5-Methyl-N-(propan-2-yl)-1,3,4-thiadiazol-2-amine | C6H11N3S | 62347-23-3 | Details |
| 2-(2,3-Dihydro-1H-inden-1-yl)ethane-1-sulfonamide | C11H15NO2S | 2031260-95-2 | Details |
| 7-Propoxy-2H-chromene-3-carboxylic acid | C13H14O4 | 923200-37-7 | Details |
| 4-(Dimethylamino)-3-fluorobenzaldehyde | C9H10FNO | 1021240-69-6 | Details |
| H-CDFLIEEIERLGQDL-OH | Details |
| 3-{2,4-Dioxo-1,3-diazaspiro[4.5]decan-3-yl}propanenitrile | C11H15N3O2 | 19283-00-2 | Details |
| BMP2K Blocking Peptide | Details |
| 6,7-Dimethyl-3,4-dihydro-2H-1-benzopyran-4-one | C11H12O2 | 80859-08-1 | Details |
| 1-Ethyl-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid | C13H16O2 | 875224-04-7 | Details |
| USP8 antibody | Details |
| 3-Methyl-1-[(1H-pyrazol-3-yl)methyl]urea | C6H10N4O | 1546298-90-1 | Details |
| (2S)-2-{[1-(2-Fluorophenyl)ethyl]amino}-3-methylbutan-1-ol hydrochloride | C13H21ClFNO | 1807941-77-0 | Details |
| 1-(2-Fluoro-5-methoxyphenyl)piperazine hydrochloride | C11H16ClFN2O | 1795395-35-5 | Details |
| MPG Blocking Peptide | Details |
| Spongistatin 1 | C63H95ClO21 | 148179-94-6 | Details |
| Methyl 2-(piperazin-1-yl)butanoate | C9H18N2O2 | 1218333-65-3 | Details |
| 3-(Pyridin-3-yl)cyclohex-2-en-1-one | C11H11NO | 63843-14-1 | Details |
| 4-(Chloromethyl)-5-(thiophen-2-yl)-1,2-oxazole | C8H6ClNOS | 1423031-02-0 | Details |
| 2,7-Dichloro-9-[(4-chlorophenyl)methylene]-9H-fluorene | C20H11Cl3 | 4364-35-6 | Details |
| 3-(3-Cyanophenoxymethyl)benzoic acid | C15H11NO3 | 342908-38-7 | Details |
| 6,7-Dibromoisoquinoline | C9H5Br2N | 1307316-84-2 | Details |
| Benzyl N-[(3-amino-1H-1,2,4-triazol-5-yl)methyl]-N-methylcarbamate | 2344677-75-2 | Details |
| 3-(2-Amino-2-carboxyethyl)pyridin-1-ium-1-olate dihydrochloride | 2375268-80-5 | Details |
| tert-Butyl N-(1-hydroxy-1-phenylpropan-2-yl)-N-methylcarbamate | C15H23NO3 | 126192-86-7 | Details |
| Haemoglobin antibody | Details |
| Adiponectin protein | Details |
| 2-Chloro-5-[(propan-2-yl)sulfamoyl]benzoic acid | C10H12ClNO4S | 74138-28-6 | Details |
| Methyl 3-[(pyridin-4-ylmethyl)amino]propanoate | C10H14N2O2 | 865075-03-2 | Details |
| 2-Fluoro-6-hydroxybenzene-1-carboximidamide hydrochloride | C7H8ClFN2O | 1797824-90-8 | Details |
| 5'-Bromo-1',2'-dihydrospiro[cyclobutane-1,3'-indol]-2'-one | C11H10BrNO | 304876-39-9 | Details |
| Product Total： Product Page： | ||||
| 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 | ||||